These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 4047178)
1. Treatment of haemodynamic and electrocardiographic side-effects resulting from imipramine toxicity in rats and dogs. Fiedler VB; Kettenbach B; Göbel H; Nitz RE Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):155-61. PubMed ID: 4047178 [TBL] [Abstract][Full Text] [Related]
2. Protective actions of carbocromene against amitriptyline-induced cardiotoxicity in anesthetized rats. Fiedler VB; Martorana PA; Nitz RE Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):103-20. PubMed ID: 3963932 [TBL] [Abstract][Full Text] [Related]
3. Protection by carbocromene and molsidomine against arrhythmias occurring during coronary artery occlusion and reperfusion in dogs. Fiedler VB; Kettenbach B; Göbel H; Nitz RE J Cardiovasc Pharmacol; 1985; 7(5):964-70. PubMed ID: 2413309 [TBL] [Abstract][Full Text] [Related]
4. Effects of carbocromene on ventricular fibrillation during acute myocardial ischemia in anesthetized dogs. Fiedler VB; Schneider S; Nitz RE Pharmacology; 1982; 25(2):96-101. PubMed ID: 7134263 [TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous carbocromene on infarct size following acute coronary artery occlusion and reperfusion in the dog. Fiedler VB; Kettenbach B; Nitz RE Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):292-308. PubMed ID: 7406585 [TBL] [Abstract][Full Text] [Related]
6. Intravenous carbochromen: a potent and effective drug for estimation of coronary dilatory capacity. Opherk D; Schuler G; Waas W; Dietz R; Kübler W Eur Heart J; 1990 Apr; 11(4):342-7. PubMed ID: 2185023 [TBL] [Abstract][Full Text] [Related]
7. The effect of carbocromene on strophanthin-induced ventricular tachycardia in dogs. Carp CI; Scholtholt J; Nitz RE Basic Res Cardiol; 1975; 70(4):434-45. PubMed ID: 1191210 [TBL] [Abstract][Full Text] [Related]
8. Effects of oral carbocromene pretreatment on infarct size following experimental coronary artery occlusion. Fiedler VB; Nitz RE; Buchheim S J Cardiovasc Pharmacol; 1982; 4(1):14-25. PubMed ID: 6176790 [TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of carbocromen in awake and anesthetized dogs with amitriptyline poisoning. Fiedler VB; Göbel H; Nitz RE J Cardiovasc Pharmacol; 1985; 7(4):666-72. PubMed ID: 2410706 [TBL] [Abstract][Full Text] [Related]
10. Effects of carbocromene on myocardial oxygen consumption in isolated dog hearts. Fiedler VB; Scholtholt J J Pharmacol Exp Ther; 1981 May; 217(2):306-13. PubMed ID: 7229974 [TBL] [Abstract][Full Text] [Related]
11. Density of plasma-perfused capillaries in the rat heart during carbocromene-induced vasodilation. Schubothe M; Vetterlein F; Schmidt G Basic Res Cardiol; 1983; 78(2):113-23. PubMed ID: 6870741 [TBL] [Abstract][Full Text] [Related]
12. [Influence of carbocromen and of other coronary dilator agents on the blood flow of a myocardial ischemic area]. Faucon G; Ollagnier M; de Claviere M; Kofman J; Evreux JC Therapie; 1975; 30(2):185-95. PubMed ID: 1162641 [No Abstract] [Full Text] [Related]
13. Imipramine induced heart failure in the dog: a model to study the effect of cardiac assist devices. Lucas CM; Cheriex EC; van der Veen FH; Habets J; van der Nagel T; Penn OC; Wellens HJ Cardiovasc Res; 1992 Aug; 26(8):804-9. PubMed ID: 1451156 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of felodipine and verapamil against imipramine-induced lethal cardiac conduction disturbances in the anaesthetized rat. Schoors DF; Reynaert H; Huyghens L; Vanhaelst L; Dupont AG Cardiovasc Drugs Ther; 1991 Apr; 5(2):489-94. PubMed ID: 1854657 [TBL] [Abstract][Full Text] [Related]
15. Anti-phosphodiesterase activity of the coronary dilating agent hydrochloride carbocromene. Aporti F; Leon A; Toffano G Pharmacol Res Commun; 1975 Jun; 7(3):289-97. PubMed ID: 167386 [No Abstract] [Full Text] [Related]
16. Intoxication by tricyclic antidepressant drugs: experimental study and therapeutic considerations. van de Ree JK; Zimmerman AN; van Heijst AN Neth J Med; 1977; 20(4-5):149-55. PubMed ID: 927613 [No Abstract] [Full Text] [Related]
17. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine. Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473 [TBL] [Abstract][Full Text] [Related]
18. [Bleeding time and cardioactive drugs. Effects of dipyridamole and carbochromen]. Rubegni M; De Mauro G; Provvedi D; Bandinelli C; Bellini PG Boll Soc Ital Cardiol; 1975; 20(8):875-80. PubMed ID: 1233046 [No Abstract] [Full Text] [Related]
19. [Letter: Influence of dipyridamole and carbochromene on bleeding time in man]. Rubegni M; Provvedi D; De Mauro G; Bandinelli C; Bellini PG Nouv Presse Med; 1975 Sep; 4(29):2117 (1). PubMed ID: 1178473 [No Abstract] [Full Text] [Related]
20. [Actions of carbocromen of toxic effects of digitalis (author's transl)]. Scholtholt VJ; Fiedler V; Göbel H; Nitz RE; Pötzsch E Arzneimittelforschung; 1976; 26(5):876-81. PubMed ID: 989361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]